Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
French firm Ceva Santé Animale is launching MilbeGuard (milbemycin oxime) flavored tablets in the US.
Pharmgate Animal Health has introduced Deracin (chlortetracycline) to control two of the most costly and challenging diseases in the US cattle industry.
The US FDA has requested animal drug companies to voluntarily revise product labels to add information about antiparasitic resistance.
Zoetis has gained US FDA approval for Revolution Plus (selamectin and sarolaner topical solution) – a monthly feline combination topical antiparasitic.
A new collaborative report from Animal Pharm and Stonehaven Consulting has highlighted the leading start-up companies in the animal health space.
The European Platform for the Responsible Use of Medicines in Animals (EPRUMA) has launched a new publication to tackle anthelmintic resistance.
Zoetis is to add to its Revolution (selamectin) canine parasiticide brand next year, by bringing a new product to market in the US.
European authorities have again recommended Boehringer Ingelheim's Longrange 50 mg/ml (eprinomectin) should not be approved.
A group of 90 researchers from 30 countries have gathered to share research and discuss coordinating an approach to developing solutions for anthelmintic resistance.
US agricultural products business American Vanguard (AMVAC) is to acquire the shares in TyraTech that it did not already own.
The US FDA is alerting pet owners and veterinarians of the possible adverse neurological events to cats and dogs associated with isoxazoline flea and tick products.
Covenant Animal Health Partners has been launched to focus on bringing animal health innovations to market.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.